Bayesian methods in palliative care research: cancer-induced bone pain.


Journal

BMJ supportive & palliative care
ISSN: 2045-4368
Titre abrégé: BMJ Support Palliat Care
Pays: England
ID NLM: 101565123

Informations de publication

Date de publication:
May 2022
Historique:
received: 12 12 2019
revised: 14 02 2020
accepted: 18 02 2020
pubmed: 7 3 2020
medline: 7 5 2022
entrez: 7 3 2020
Statut: ppublish

Résumé

To show how a simple Bayesian analysis method can be used to improve the evidence base in patient populations where recruitment and retention are challenging. A Bayesian conjugate analysis method was applied to binary data from the Thermal testing in Bone Pain (TiBoP) study: a prospective diagnostic accuracy/predictive study in patients with cancer-induced bone pain (CIBP). This study aimed to evaluate the clinical utility of a simple bedside tool to identify who was most likely to benefit from palliative radiotherapy (XRT) for CIBP. Recruitment and retention of patients were challenging due to the frail population, with only 27 patients available for the primary analysis. The Bayesian method allowed us to make use of prior work done in this area and combine it with the TiBoP data to maximise the informativeness of the results. Positive and negative predictive values were estimated with greater precision, and interpretation of results was facilitated by use of direct probability statements. In particular, there was only 7% probability that the true positive predictive value was above 80%. Several advantages of using Bayesian analysis are illustrated in this article. The Bayesian method allowed us to gain greater confidence in our interpretation of the results despite the small sample size by allowing us to incorporate data from a previous similar study. We suggest that this method is likely to be useful for the analysis of small diagnostic or predictive studies when prior information is available.

Identifiants

pubmed: 32139358
pii: bmjspcare-2019-002160
doi: 10.1136/bmjspcare-2019-002160
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e5-e9

Subventions

Organisme : Marie Curie
ID : MCCC-RP-15-A19005
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Richard A Parker (RA)

Edinburgh Clinical Trials Unit, Usher Institute, The University of Edinburgh, Edinburgh, UK Richard.parker@ed.ac.uk.

Tonje A Sande (TA)

Usher Institute, The University of Edinburgh, Edinburgh, UK.

Barry Laird (B)

Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

Peter Hoskin (P)

Mount Vernon Cancer Centre, Northwood, Middlesex, UK.
Division of Cancer Sciences, The University of Manchester, Manchester, Manchester, UK.

Marie Fallon (M)

Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

Lesley Colvin (L)

Division of Population Health and Genomics, University of Dundee, Dundee, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH